Table 1.

Characteristics of patients with pSS and control subjects. Values are n (%) unless otherwise specified.

CharacteristicspSS, n = 2686Control, n = 10,744p
Age, yrs, median (IQR)45.31 (32.99–57.98)45.26 (32.93–57.99)0.996
Age distribution
  20–391068 (39.8)4272 (39.8)0.946
  40–591030 (38.3)4120 (38.3)
  ≥ 60588 (21.9)2352 (21.9)
Sex
  Male760 (28.3)3040 (28.3)> 0.999
  Female1926 (71.7)7704 (71.7)
Income
  Low1098 (40.9)5194 (48.3)< 0.001*
  Medium1050 (39.1)4175 (38.9)
  High538 (20.0)1375 (12.8)
Degree of urbanization
  Urban1695 (63.1)6729 (62.6)0.170
  Suburban754 (28.1)3152 (29.3)
  Rural199 (7.4)863 (8.0)
Comorbidities
  Hypertension517 (19.2)1916 (17.8)0.092
  Diabetes mellitus348 (13.0)1138 (10.6)0.001*
  Dyslipidemia499 (18.6)1341 (12.5)< 0.001*
  Coronary artery disease22 (0.8)71 (0.7)0.367
  Congestive heart failure66 (2.2)202 (1.9)0.241
  Chronic pulmonary disease431 (16.0)1031 (9.6)0.001*
  Malignancy58 (2.2)193 (1.8)0.231
Followup, yrs, median (IQR)4.70 (2.93–7.17)4.70 (2.93–0.17)0.866
  Newly diagnosed psychiatric disorders215 (8.00)475 (4.4)< 0.001*
  Schizophrenia2 (0.1)24 (0.2)0.143
  Bipolar disorder6 (0.2)15 (0.1)0.409
  Depressive disorder85 (3.2)174 (1.6)< 0.001*
  Anxiety disorder67 (2.5)145 (1.3)< 0.001*
  Sleep disorder55 (2.0)117 (1.1)< 0.001*
  • * Statistical significance. pSS: primary Sjögren syndrome; IQR: interquartile range.